#cancernetwork #RCC #kidneycancerawareness
The fibroblast growth factor (FGF) inhibitor dovitinib failed to improve progression-free survival outcomes as a third-line treatment for patients with metastatic renal cell carcinoma compared with sorafenib, according to the results of a phase III study.
The results of a retrospective study indicated that patients with metastatic gastrointestinal stromal tumors (GIST) who are able to achieve complete macroscopic surgical resection of their disease may be able to achieve long-term survival.
The risk for burnout appears to rise in direct proportion to the number of hours oncologists spend on direct patient care, according to a recent survey by the American Society of Clinical Oncology (ASCO).
A 50-year-old male is receiving capecitabine with concurrent radiation therapy for stage III rectal cancer. For the past 7 days, the patient has been taking ciprofloxacin for a urinary tract infection. He has a 1-week history of a tingling sensation in both the palms of his hands and soles of his feet, and a 3-day history of hand edema and erythema.
The diagnosis is?
#cancernetwork #leukemia #lymphoma
Contrary to some previous research as well as popular belief, living underneath or near to power lines as a child may not have any notable effect on childhood leukemia risk, according to a new case-control study conducted in the United Kingdom.
Through a variety of clinical, educational, and practice management tools, Cancer Network is designed to meet the informational needs of today's busy cancer care specialist.
Offering an array of clinical content highlighting the latest research, updates from important medical meetings, CME opportunities, and access to the Cancer Management Handbook, Cancer Network is considered to be a leading source of information among the community of cancer care clinicians.